Mironid
PrivateLast Round
Series B
Aug 5, 2026
Total Funding Raised
$90.55M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Mironid operates in Healthcare & Life Sciences and is based in Glasgow. Its latest recorded funding round was a Series B round in August 2026.
Mironid is a biopharmaceutical company developing small molecule therapeutics for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mironid Comparables
Compare Mironid with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Estuary Biotherapeutics | 84% | |
| Renasant Bio | 81% | |
| XORTX Therapeutics Inc. | 79% |
For institutional investors. Book with your work email.
Mironid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 5, 2026 | ||||
| Series A Extension | Sep 13, 2023 | ||||
| Series A | Jun 20, 2016 |
For institutional investors. Book with your work email.
Mironid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series B, Series A Extension, Series A |
| Epidarex Capital | Series B, Series A Extension, Series A |
| European Investment Fund | Series A Extension, Series A |
| Scottish National Investment Bank | Series B |
| Sofinnova Partners | Series B, Series A Extension, Series A |
| University of Strathclyde | Series B, Series A Extension, Series A |
| BioGeneration Ventures | Series B, Series A Extension, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2026
$46M round with participation from BioGeneration Ventures and Epidarex Capital.
- Jun 19, 2026
Monthly visitors increased 58% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresNov 12, 2026
Mironid welcomes Omar to its Board.
- hiresNov 12, 2026
Mironid appoints Dr. Omar Khwaja as Non-Executive Director of the Board in Scotland on Nov 12th '26.
- receives_financingAug 17, 2026
Mironid receives $64.1M in Series B financing from Scottish National Investment Bank, Roche Venture Fund, Epidarex Capital, Sofinnova Partners, BioGeneration Ventures, and the University of Strathclyde to support rare kidney disease research.
For institutional investors. Book with your work email.
Mironid Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mironid's valuation, stock price, and market status.
Is Mironid a public or private company?
Mironid is a private company.
What is the current stock price of Mironid?
Mironid is a private company, so its shares have no public market price. Caplight tracks Mironid's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mironid worth (valuation)?
Valuation information for Mironid is not publicly available.
Can I buy Mironid stock?
Mironid shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mironid's last funding round?
Mironid's most recent funding round was Series B on August 5, 2026.
Who are the main investors in Mironid?
Key investors in Mironid include Roche Venture Fund, Epidarex Capital.
Will Mironid IPO soon?
No public IPO plans have been announced for Mironid.
How can I track Mironid secondary market activity?
Caplight tracks bids, offers, and trades in Mironid's shares on secondary markets.